BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36550175)

  • 1. Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator.
    Ogata M; Oh H; Nakata A; Doi A; Nakayama H; Hasegawa M; Hirose M
    Sci Rep; 2022 Dec; 12(1):22139. PubMed ID: 36550175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND SURGICAL OUTCOMES OF TISSUE PLASMINOGEN ACTIVATOR-ASSISTED VITRECTOMY FOR SUBMACULAR HEMORRHAGE SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Hirashima T; Moriya T; Bun T; Utsumi T; Hirose M; Oh H
    Retina; 2015 Oct; 35(10):1969-78. PubMed ID: 26079475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGE.
    Miki M; Miyata M; Ooto S; Tamura H; Ueda-Arakawa N; Muraoka Y; Miyake M; Hata M; Takahashi A; Kido A; Kogo T; Uji A; Tsujikawa A
    Retina; 2023 Nov; 43(11):1971-1979. PubMed ID: 37490778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.
    Caporossi T; Bacherini D; Governatori L; Oliverio L; Di Leo L; Tartaro R; Rizzo S
    Acta Ophthalmol; 2022 Aug; 100(5):e1143-e1152. PubMed ID: 34609787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P; Tsiropoulos GN; Koronis S; Vakalis A; Asteriadis S; Stavrakas P
    Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
    Barayev E; Tiosano A; Zlatkin R; Elul R; Dotan A; Hadayer A; Gal-Or O; Ehrlich R
    Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S; Kumar JB; Kim JE; Thordsen J; Dayani P; Ober M; Mahmoud TH
    Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.
    Sniatecki JJ; Ho-Yen G; Clarke B; Barbara R; Lash S; Papathomas T; Antonakis S; Gupta B
    Eur J Ophthalmol; 2021 Mar; 31(2):643-648. PubMed ID: 31813290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gravitational displacement of submacular haemorrhage in patients with age-related macular disease.
    Erdogan G; Kirmaci A; Perente I; Artunay O
    Eye (Lond); 2020 Jun; 34(6):1136-1141. PubMed ID: 31792350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.
    Kimura S; Morizane Y; Hosokawa MM; Shiode Y; Doi S; Hosogi M; Fujiwara A; Okanouchi T; Inoue Y; Shiraga F
    Jpn J Ophthalmol; 2019 Sep; 63(5):382-388. PubMed ID: 31243593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
    Kishikova L; Saad AAA; Vaideanu-Collins D; Isac M; Hamada D; El-Haig WM
    Eur J Ophthalmol; 2021 Sep; 31(5):2621-2624. PubMed ID: 32993349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VITRECTOMY WITH SUBRETINAL INJECTION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR FOR SUBMACULAR HEMORRHAGE WITH OR WITHOUT VITREOUS HEMORRHAGE.
    Shi T; Wen J; Xia H; Chen H
    Retina; 2024 Jul; 44(7):1188-1195. PubMed ID: 38452260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naïve subretinal haemorrhage due to neovascular age-related macular degeneration. pneumatic displacement, subretinal air, and tissue plasminogen activator: subretinal vs intravitreal aflibercept-the native study.
    Iglicki M; Khoury M; Melamud JI; Donato L; Barak A; Quispe DJ; Zur D; Loewenstein A
    Eye (Lond); 2023 Jun; 37(8):1659-1664. PubMed ID: 36038720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of submacular hemorrhage: experience at an academic Canadian centre.
    Juncal VR; Hanout M; Altomare F; Chow DR; Giavedoni LR; Muni RH; Wong DT; Berger AR
    Can J Ophthalmol; 2018 Aug; 53(4):408-414. PubMed ID: 30119797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F; Klatt C; Roider J; Hillenkamp J
    Br J Ophthalmol; 2010 Jan; 94(1):48-53. PubMed ID: 19946027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective multicenter survey.
    Inoue N; Kato A; Araki T; Kimura T; Kinoshita T; Okamoto F; Murakami T; Mitamura Y; Sakamoto T; Miki A; Takamura Y; Matsubara H; Tsujinaka H; Gomi F; Yasukawa T
    PLoS One; 2022; 17(7):e0271447. PubMed ID: 35862313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.